Parents cautious of new FDA-approved device for kids with ADHD
The U.S. Food and Drug Administration’s approval of the first medical device of its kind to treat ADHD in children between the ages of 7 and 12 years-old is being met with "cautious optimism" by parents and advocates. The new device known as the Monarch eTNS system will cost parents about $1,000 and isn’t yet covered by insurance.
Other Articles in this Edition
Parents cautious of new FDA-approved device for kids with ADHD
ADHD Tied to Short Stature in Early Childhood
Does Diet Affect a Child’s ADHD?
Maternal cotinine levels linked to ADHD in offspring
Children With ADHD More Likely To Engage In Substance Use At Earlier Ages
Adults with ADHD represent an important subgroup of OCD
Brain’s support network may play key role in attention deficit, hyperactivity behaviors